65 Clyde Road
Suite A
Somerset, NJ 08873
United States
732 873 4040
https://accessbio.net
Sector(s):
Industry:
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Young-Ho Choi | CEO & President | 1.56B | N/A | 1964 |
Bo-Kyung Choi | Managing Director | 968.91M | N/A | N/A |
Young-Seok Hong | Managing Director | 642.38M | N/A | N/A |
Mr. John Kim | Managing Partner | N/A | N/A | N/A |
Mr. Philip Kim CPA | Treasurer and Member of the Advisory Board | N/A | N/A | N/A |
Ms. Janet Strong Ph.D. | DOD/Government Issues Advisor and Member of the Advisory Board | N/A | N/A | N/A |
Mr. Andrew J. Gorman | Business Advisor and Member of the Advisory Board | N/A | N/A | N/A |
N. A. Shaikh M.D., Ph.D. | Clinical Advisor and Member of the Advisory Board | N/A | N/A | N/A |
Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources; analyzers, designed to measure different chemicals and other characteristics in biological samples; and molecular diagnostic solutions used in analyzing biological markers in the genome and proteome. It offers its products under CareStart, CareUS, CareSURE, and CareGENE brand names. The company was incorporated in 2002 and is headquartered in Somerset, New Jersey.
Access Bio, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.